Disc Medicine, Inc.
IRON
Rang in Aktien
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Aktienkurs
$75.39
Zuletzt synchronisiert: 2026-10-22
Marktkapitalisierung
$2.89B
Veränderung (1 Tag)
-0.80%
Veränderung (1 Jahr)
-9.92%
Land
US
Handel Disc Medicine, Inc. (IRON)
Kategorie
Healthcare
Kursverlauf für Disc Medicine, Inc. (IRON)
Höchster Schlusskurs: $64.58 am 2026-10-01
Niedrigster Schlusskurs: $104.87 am 2020-08-01
Niedrigster Schlusskurs: $104.87 am 2020-08-01
Kursverlauf der Aktie von Disc Medicine, Inc. von 2020 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -15.22% |
| 2025 | 35.37% |
| 2024 | 10.81% |
| 2023 | 264.05% |
| 2022 | -41.22% |
| 2021 | -73.71% |
| 2020 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $536.13 | 26.86% |
US
|
|
| $200.12 | 662.34% |
US
|
|
| $137.17 | -3.22% |
AU
|
|
| $291.76 | 1.91% |
BE
|
|
| $880.01 | 8.35% |
NL
|
